This is in connection with our letter dated April 23, 2025 informing about the decision taken by the Board of Directors of the Company approving the Scheme of Amalgamation ("Scheme") between ....
PRAVEG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Praveg Limited has received a 'no adverse observations' letter from BSE on January 21, 2026 for its proposed Scheme of Amalgamation with Eulogia Inn Private Limited. The scheme, first approved by the Board on April 23, 2025, involves the merger of the unlisted Eulogia Inn into the listed Praveg Limited. BSE has given its clearance subject to certain conditions, including disclosing details of ongoing legal proceedings, providing financial details of unlisted entities in the shareholder notice, and ensuring compliance with SEBI circulars. The observation letter is valid for six months, within which the scheme must be filed with the National Company Law Tribunal (NCLT). The merger still requires approvals from NCLT, shareholders, and creditors of both companies before it can be implemented.
This is a positive procedural step forward for the merger, clearing one of the key regulatory hurdles. However, the deal is far from finalized — NCLT and shareholder/creditor approvals are still pending, and the swap ratio has not been disclosed in this filing, leaving uncertainty for investors about the financial terms.